UK markets closed

Oragenics, Inc. (OGEN)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
2.3300+0.6900 (+42.07%)
At close: 04:00PM EDT
2.3401 +0.01 (+0.43%)
After hours: 07:57PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
-
0
0
0
Operating expenses
Research development
5,861
-
10,073
10,586
22,108
Selling general and administrative
4,580
-
4,480
5,272
4,534
Total operating expenses
10,408
-
14,421
15,772
26,644
Operating income or loss
-10,408
-
-14,421
-15,772
-26,644
Interest expense
24.173
-
15.103
15.756
10.685
Total other income/expenses net
47.112
-
11.582
0.67
134.548
Income before tax
-10,146
-
-14,288
-15,712
-26,431
Income tax expense
0
-
0
0
0
Income from continuing operations
-10,146
-
-14,288
-15,712
-26,431
Net income
-10,146
-
-14,288
-15,712
-26,431
Net income available to common shareholders
-10,146
-
-14,288
-15,712
-26,431
Basic EPS
-4.60
-9.18
-7.11
-8.09
-28.20
Diluted EPS
-4.60
-9.18
-7.11
-8.09
-28.20
Basic average shares
2,155
2,250
2,009
1,943
942.187
Diluted average shares
2,155
2,250
2,009
1,943
942.187